NASDAQ: NVUS       Novus Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.587   +0.007 (1.21%)  0.581 - 0.664  21,807


Avg Volume (4 weeks):182,611
4 Weeks Range:0.56 - 0.99
4 Weeks Price Volatility (%):
52 Weeks Range:0.40 - 5.21
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction.

  Be the first to like this.


3345  2280  417  2920 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 PFE 38.455-1.705 
 ECA 3.79-0.25 
 F 8.94+0.05 
 VXRT 0.88+0.238 
 NIO 4.189+0.179 
Partners & Brokers